DLX1 and pachyonychia congenita: The two-gene risk level, which combines sixth homeobox clustering and DLX1 mRNA levels of expression with typical medical risk factors, can efficiently determine high-grade, medically necessary PC so it could be seen in decision-making, lowering the amount of unwanted prostatic biopsies and prospective overdiagnosis.